www.bioscience.co.uk
Sales & Support: +44 (0)1223 316 855

*

SAA-1, Human, mAb Reu86.5

Catalogue number:
HM2101-20UG
Supplier:
Size:
20 µg _$$_
Product is available in:
  • UK
  • Ireland
  • Europe
  • USA
  • Rest of World
£132.00 Shipping is calculated in checkout
Applications:

Frozen sections, Immuno assays, Paraffin sections, Western blot

Product Description:

The serum amyloid A (SAA) family comprises a number of differentially expressed apolipoproteins, acute-phase SAA1 and SAA2, the former being the major component in plasma, and constitutive SAAs (C-SAAs). Although the liver is the primary site of synthesis of both SAA types extrahepatic production has been reported. The in vivo concentrations increase by as much as 1000-fold during inflammation. Several studies have stressed its importance in the diagnosis and monitoring of various diseases. Pathological SAA values are often detected in association with normal CRP concentrations; SAA rises earlier and more sharply than CRP.Recently, a broader view of SAA expression and function has been emerging. Expression studies show production of SAA proteins in histologically normal, atherosclerotic, Alzheimer, inflammatory, and tumor tissues. SAA has been found to have binding sites for high density lipoproteins, calcium, laminin, and heparin/heparan-sulfate. Also adhesion motifs were identified and new functions, affecting cell adhesion, migration, proliferation and aggregation discovered. These findings emphasize the importance of SAA in various physiological and pathological processes, including inflammation, atherosclerosis, thrombosis, AA-amyloidosis, rheumatoid arthritis, and neoplasia. SAA has also a number of immunomodulatory roles, it can induce chemotaxis and adhesion molecule expression, has cytokine-like properties and can promote the upregulation of metalloproteinases. It enhances the binding of high-density lipoprotein to macrophages and thus helps in the delivery of lipids to sites of injury for use in tissue repair. It is thus thought to be an integral part of the disease processes. In addition, recent experiments suggest that SAA may play a "housekeeping" role in normal human tissues.Elevated levels of SAA over time predispose to secondary amyloidosis, extracellular accumulation of amyloid fibrils, derived from a circulating precursor, in various tissue and organs. The most common form of amyloidosis occurs secondary to chronic inflammatory disease, particularly rheumatoid arthritis.The antibody is raised against human SAA and Helix Pomatia Haemocyanine. It reacts with the SAA-1 type.

HM2101-20UG SAA-1, Human, mAb Reu86.5
HM2101-20UG SAA-1, Human, mAb Reu86.5
Details Cat number & supplier Size Price
SAA-1, Human, mAb Reu86.1 HM2100-20UG · Hycult Biotech
HM2100-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
CD46, Human, mAb M177 HM2103-20UG · Hycult Biotech
HM2103-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
JAM-A, Human, mAb M.Ab.F11 HM2099-20UG · Hycult Biotech
HM2099-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
ICAM-1, Human, mAb HM.2 HM2104-20UG · Hycult Biotech
HM2104-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
JAM-A, Human, mAb BV16 HM2098-20UG · Hycult Biotech
HM2098-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
DAF, Human, mAb D17 HM2105-20UG · Hycult Biotech
HM2105-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
DAF, Human, mAb D17, FITC HM2105F-20UG · Hycult Biotech
HM2105F-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
TLR3, Human, mAb TLR3.7 HM2096-20UG · Hycult Biotech
HM2096-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
C5aR, Human, mAb W17/1 HM2095-20UG · Hycult Biotech
HM2095-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
C1s, Human, mAb M81 HM2108-20UG · Hycult Biotech
HM2108-20UG
Hycult Biotech
20 µg £132.00
20 µg
view